Home > Boards > US Listed > Cannabis > Zynerba Pharmaceuticals (ZYNE)

The truth...will set you free.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
dhbuzz Member Profile
 
Followed By 8
Posts 1,852
Boards Moderated 0
Alias Born 03/01/19
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 12/2/2019 1:38:19 PM
Zynerba Pharmaceuticals Receives New U.S. Patent for Treatment of Fragile X Syndrome with Transdermal Cannabidiol GlobeNewswire Inc. - 11/12/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/6/2019 8:17:50 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/6/2019 7:01:31 AM
Zynerba Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational Highlights GlobeNewswire Inc. - 11/6/2019 6:45:00 AM
Bernstein Liebhard LLP Announces the Filing of a Securities Class Action Against Zynerba Pharmace... PR Newswire (US) - 10/28/2019 10:42:00 AM
Zynerba Pharmaceuticals to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference GlobeNewswire Inc. - 10/25/2019 1:45:05 PM
Bernstein Liebhard LLP Announces the Filing of a Securities Class Action Against Zynerba Pharmace... Business Wire - 10/25/2019 12:06:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/2/2019 4:06:28 PM
Zynerba Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire Inc. - 9/26/2019 11:50:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/24/2019 7:05:14 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/18/2019 7:14:48 AM
Zynerba Pharmaceuticals Announces Positive Top Line Data from BELIEVE 1 Open Label Phase 2 Study of Zygel™ in Developmental... GlobeNewswire Inc. - 9/18/2019 6:30:00 AM
New Caregiver-Reported Data Further Validate the Use of the Aberrant Behavior Checklist Community: FXS Specific (ABC-CFXS) Su... GlobeNewswire Inc. - 9/5/2019 7:00:00 AM
Autism Spectrum Disorder, Fragile X Syndrome, and 22q11.2 Deletion Syndrome Share a Constellation of Sociobehavioral Symptoms... GlobeNewswire Inc. - 9/5/2019 7:00:00 AM
Zynerba Pharmaceuticals to Present at Two Upcoming Conferences GlobeNewswire Inc. - 9/3/2019 11:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/30/2019 4:27:58 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/30/2019 4:02:14 PM
Zynerba Pharmaceuticals Announces Poster Presentations at the 22nd Society for the Study of Behavioural Phenotypes (SSBP) Sym... GlobeNewswire Inc. - 8/29/2019 7:30:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 8/14/2019 6:00:55 AM
Zynerba Pharmaceuticals Announces Publication of Zygel™ (ZYN002) 12-week Open Label Fragile X Syndrome Data in the Journal ... GlobeNewswire Inc. - 8/7/2019 6:12:00 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/6/2019 8:14:23 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2019 7:05:52 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2019 7:01:50 AM
Zynerba Pharmaceuticals Reports Second Quarter 2019 Financial Results and Operational Highlights GlobeNewswire Inc. - 8/6/2019 6:45:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2019 InvestorsHub.com, Inc.